Crossmark

Methylation-directed regulatory networks determine enhancing and silencing of mutation disease driver genes and explain inter-patient expression variation

Crossref DOI link: https://doi.org/10.1186/s13059-023-03094-6

Published Online: 2023-11-28

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Edrei, Yifat

Levy, Revital

Kaye, Daniel

Marom, Anat

Radlwimmer, Bernhard

Hellman, Asaf http://orcid.org/0000-0002-5252-6894
Funding

Funding for this research was provided by:

Heidelberger Zentrum für Personalisierte Onkologie Deutsches Krebsforschungszentrum In Der Helmholtz-Gemeinschaft (DKFZ-HIPO)

HORIZON EUROPE European Research Council (724803)

Israel Science Foundation (948/16, 3413/19)
License Information

Text and Data Mining valid from 2023-11-28

Version of Record valid from 2023-11-28
More Information

Article History

Received: 23 May 2022

Accepted: 23 October 2023

First Online: 28 November 2023

Declarations

:

: Tumor biopsies were collected as described [CitationRef removed]. Informed consent was obtained from all patients.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below